Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 12676 - 12677 of 12677 in total
Allocetra is a novel therapy where billions of early apoptotic cells are infused into the bloodstream of a patient, using the body's own natural regulation mechanisms to rebalance an unbalanced immune system without immune system suppression. With infusion, the body's macrophages and dendritic cells can feed on these early apoptotic...
Investigational
Matched Description: … body's macrophages and dendritic cells can feed on these early apoptotic Allocetra cells and thus result in
XAV-19 is an intravenous antibody-based treatment targeted towards SARS-CoV-2 and other coronaviruses[L16553,L16558]. The therapy concept is based on COVID-19 convalescent plasma. However, rather than using human plasma, XAV-19 is a heterologous swine glyco-humanized polyclonal antibody that targets the spike protein of SARS-CoV-2[L16553,L16558]. The therapy offers three beneficial effects: the ability...
Investigational
Matched Description: … pharmaceutical company, to develop XAV-19, and with Nantes University Hospital to test the treatment in
Displaying drugs 12676 - 12677 of 12677 in total